Company Overview and News

104
China’s national champion in voice-recognition tech is moving into hardware in a big way

2018-06-18 scmp
Shenzhen-listed iFlytek is collaborating with telecoms network operators China Mobile, China Unicom and China Telecom to bring voice-activated smart devices to the mass market
0941 BABA 0762 CHLKF CHL CHJHF CHUFF 0700 CHA CMCM 0728 CHU

7
Bear of the Day: Hain Celestial (HAIN)

2018-06-13 zacks
A leading name in the organic and natural products space, Hain Celestial Group Inc. (HAIN - Free Report) operates primarily in North America, Europe, and India. Its mission is to be the leading marketer, manufacturer and seller of organic and natural, better-for-you products. Hain is headquartered in Boulder, CO.
CHJHF CHA HAIN 0728 TRI LB UTX

7
Bear of the Day: Thomson Reuters (TRI)

2018-06-12 zacks
Thomson Reuters (TRI - Free Report) , a Zacks Rank #5 (Strong Sell), is a leading provider of value-added information and technology to users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate training and assessment, scientific research and healthcare.
CHJHF CHA 0728 TRI LB DLPH

18
American Axle (AXL) to Deliver AWD PTUs for Ford Crossovers

2018-06-12 zacks
American Axle & Manufacturing Holdings, Inc. (AXL - Free Report) has signed a business contract with Ford Motor Company (F - Free Report) . Per the contract, American Axle will supply Power Transfer Units (PTU) for Ford’s crossover vehicles. American Axle’s all-wheel drive (AWD) PTUs will be initially used in 2019 Ford Edge and Lincoln Nautilus models.
CHJHF AXL TM CHA 7203 0728 TYT TOYOF

50
Should WisdomTree U.S. SmallCap Earnings Fund (EES) Be on Your Investing Radar?

2018-06-12 zacks
Launched on 02/23/2007, the WisdomTree U.S. SmallCap Earnings Fund (EES - Free Report) is a passively managed exchange traded fund designed to provide a broad exposure to the Small Cap Value segment of the US equity market.
KEM MTCH CHJHF VBR CHA 0728 IWN

135
Trump, Kim Clinch Historic Deal: 6 Top-Ranked Winners

2018-06-12 zacks
Exceptional bonhomie was on display when President Trump and North Korea’s leader Kim Jong Un met in Singapore on Tuesday. This was the first meeting between a sitting U.S. President and a North Korean chairman.
CHJHF MU WDC CHA STX 0728 DLA MBUU RCKY

139
Play FIFA World Cup 2018 With These Stocks

2018-06-12 zacks
The 2018 FIFA World Cup at Russia will take full charge ofsports lovers all over the world till Jul 15. For the coming one month, sponsors of the event will put up hoardings and adopt every means of advertisement to promote their brands. According to marketing agency Zenith, the event will likely inject about $2.4 billion to the global advertising market.
MGM FB PDYPY CHJHF ADDYY CCV CHA MS.PRE MS.PRF MS.PRG CCZ MS.PRA NKE TWTR GKNGY MS CMCSK FOX CMCSA MS.PRI CCV.CL MS.PRK 0728 LVS FOXA

28
New Strong Sell Stocks for June 12th

2018-06-12 zacks
AMN Healthcare Services, Inc. (AMN - Free Report) is a provider of healthcare workforce solutions and staffing services. The Zacks Consensus Estimate for its current year earnings has been revised 3.3% downward over the last 60 days.
BHVN AMN BCML CHJHF BCBP CHA 0728 AHS AIT AMBA

3
5 Value Stocks With Enticing EV/EBITDA Ratios to Own Now

2018-06-12 zacks
Value investors generally tend to cling to the price-to-earnings (P/E) strategy while looking for stocks that are trading at a bargain. Undoubtedly, P/E is the most popular multiple used by investors for assessing the fair market value of a stock. However, even this straightforward, broadly used valuation metric suffers a few downsides. EV/EBITDA is a Better Option, Here’s Why? Although P/E is the most commonly used tool for evaluating a firm’s value, another valuation metric called EV/EBITDA works even better.
AAWW CHJHF UGI CHA 0728 CVTI

1
Is FHAIX a Strong Bond Fund Right Now?

2018-06-12 zacks
If investors are looking at the High Yield - Bonds fund category, make sure to pass over Franklin High Income A (FHAIX - Free Report) . FHAIX carries a Zacks Mutual Fund Rank of 4 (Sell), which is based on nine forecasting factors like size, cost, and past performance.
CHJHF CHA 0728 FHAIX

11
Douglas Emmett Sees Hammer Chart Pattern: Time to Buy?

2018-06-12 zacks
Douglas Emmett, Inc. (DEI - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because DEI recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
DEI CHJHF CHA 0728 AIT

10
America First Multifamily Investors Sees Hammer Chart Pattern: Time to Buy?

2018-06-12 zacks
America First Multifamily Investors, L.P. (ATAX - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because ATAX recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
CHJHF CHA 0728 AIT ATAX

35
Why Did Facebook (FB) Stock Climb Monday?

2018-06-12 zacks
Shares of Facebook (FB - Free Report) popped 1.29% to close at $191.54 per share on Monday after the company announced its new “Memories” page. But there is a little bit more to the story.
FB CHJHF CHA 0728

45
Vale (VALE) Might Stream $700M Voisey's Bay's Cobalt Output

2018-06-11 zacks
Per media reports, Vale S.A. (VALE - Free Report) will sell about $700-million cobalt produced in its Canada Voisey’s Bay open-pit mine to meet rising demand from vehicle battery makers. Of late, Vale has been trying to gather funds to transform the open-pit operations of this mine to an underground one. Notably, prior to this, the company had expressed interest in streaming the arrangement of the mine.
RIO RIO BLT CHJHF BHPBF CHA RTPPF BHP RIO RTNTF BBL 0728 BHP BHPLF

33
Adidas vs Nike: Which Sportswear Giant Will Win the FIFA World Cup?

2018-06-11 zacks
The 2018 FIFA World Cup in Russia kicks off Thursday on Fox (FOXA - Free Report) . The month-long tournament is expected to attract billions of viewers from over 200 countries, making it a marketing dream. The likes of Coca-Cola (KO - Free Report) , Visa (V - Free Report) , Budweiser (BUD - Free Report) , and McDonald’s (MCD - Free Report) will all be heavily featured, but Adidas (ADDYY - Free Report) and Nike (NKE - Free Report) are the only companies competing against each other.
UA V NKE CHJHF ADDYY UAA TWTR CHA 0728

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...